Acute Respiratory Distress Syndrome Research Report 2024: Market to Grow at a CAGR of 8.7% During 2025-2030, Driven by Technological Advances in Diagnostics and Therapies
October 23, 2024 06:28 ET
|
Research and Markets
Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Acute Respiratory Distress Syndrome Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by End-User, Mode of Administration,...
Bronchiolitis Obliterans Syndrome Drug Pipeline Research Report 2024: Therapeutic Assessment, Emerging Drugs, Pipeline Development Activities, Competitive Landscape
October 14, 2024 10:36 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Bronchiolitis...
COPD Seven (US, France, Germany, Italy, Spain, UK, Japan) Drug Market Analysis & Forecasts 2024: Sales to Reach $30.8 Billion in 2033 - GSK, AstraZeneca, and Sanofi/Regeneron Compete for First Place
October 11, 2024 06:35 ET
|
Research and Markets
Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "COPD: Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM (US,...
U.S. COPD Treatment Awareness & Satisfaction Report 2023-2024: Understand HCP Treatment Discussions, Treatment Satisfaction & Awareness, Clinical Trial Interest, and Much More
September 26, 2024 04:14 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "COPD in the United States: A Review of 2023 - Key Insights into Treatment Awareness & Satisfaction" report has been added to ...
Amoxicillin Market Research Report 2024: Combination Therapies and Immunotherapy Trends Shaping Future Landscape - Global Long-term Forecast to 2028 and 2033
September 26, 2024 04:02 ET
|
Research and Markets
Dublin, Sept. 26, 2024 (GLOBE NEWSWIRE) -- The "Amoxicillin Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The amoxicillin market size has grown steadily in...
Respiratory Collaboration and Licensing Agreements Trends Analysis Report 2024 with Upfront, Milestone, and Royalties Data for 415 Deals
September 25, 2024 09:19 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Fully revised and updated, the...
Chronic Refractory Cough Pipeline Landscape Report 2024 Featuring GSK and Trevi Therapeutics
September 25, 2024 04:11 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "Chronic Refractory Cough - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The Chronic Refractory Cough (CRC)...
Alpha-1 Antitrypsin Drugs Global Strategic Research Report 2024: Advances in Biomarker Identification Generate New Opportunities for Targeted Therapies - Forecast to 2030
September 20, 2024 09:24 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Chronic Obstructive Pulmonary Disease (COPD) Epidemiology Forecast to 2033: Focus on US, France, Germany, Italy, Spain, UK, and Japan
September 13, 2024 06:56 ET
|
Research and Markets
Dublin, Sept. 13, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. In the...
Chronic Obstructive Pulmonary Disease (COPD) Market Forecast Report and Company Analysis 2024-2032 Featuring AstraZeneca, Pfizer, GSK, Novartis, Astellas, Abbott, Boehringer Ingelheim, Almirall
September 10, 2024 05:12 ET
|
Research and Markets
Dublin, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease, Market Report, Forecast by Types, Treatment Types, Distribution Channels, Countries and Company Analysis,...